Menu Back toLS18: Guiding RWE Utilization for Regulatory Decision Making in US, EU and Japan

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

LS18: Guiding RWE Utilization for Regulatory Decision Making in US, EU and Japan

Session Chair(s)

Yoshiaki Uyama, PhD, RPh

Yoshiaki Uyama, PhD, RPh

  • Associate Executive Director
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Speaker(s)

Gerald J. Dal Pan, MD, MHS

Gerald J. Dal Pan, MD, MHS

  • Director, Office of Surveillance and Epidemiology, CDER
  • FDA, United States
Gianmario Candore

Gianmario Candore

  • Data Scientist
  • European Medicines Agency, Netherlands
Yoshiaki Uyama, PhD, RPh

Yoshiaki Uyama, PhD, RPh

  • Associate Executive Director
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Contact us

Questions?

Send Email
+81.3.6214.0574